NEW YORK — GeneMatters and Concert Genetics said on Wednesday that they have signed an agreement to integrate their respective technologies into a clinical genetics services platform.
Under the terms of the deal, the companies will combine Concert's software-as-a-service platform for genetic test ordering and results management with GeneMatters' virtual genetic counselors, care delivery software, and patient engagement tools.
Financial and other terms of the agreement were not disclosed.
"By partnering with GeneMatters, we can combine their proven tech-enabled care delivery with Concert's test order management platform to provide seamless, end-to-end genetics services to leading healthcare organizations and the patients they serve," Concert CEO Rob Metcalf said in a statement.
Both companies have struck related deals with others in the past. In December, Nashville, Tennessee-based Concert partnered with Trapelo Health to offer technologies for oncology decision support. In mid-2019, Minneapolis-based GeneMatters formed an alliance with CancerIQ to provide genetic counseling services to high-risk cancer patients.